2Bleiberg H. Oxaliplatin (L-OHP): a new reality in colorectal cancer[J]. Br J Cancer, 1998, 77(4):1-3.
3Becouarn Y, Ychou M, Ducreux M, et al. Phase Ⅱ trail of oxaliplatin as first line chemotherapy in metastatic cororectal cancer patients[J]. J Clin Oncol,1998,16(8):2739-2744.
1Reardon J T, Sancar A. Molecular mechanism of nucleotide excision repair in mammalian cells[M]. New York: Plenum Publishing Corp, 1998: 377-393.
2Wilson M D, Ruttan C C, Koop B F, et al. ERCC1: A comparative genomic perspective [ J ]. Environ Mol Mutagen, 2001, 38(2) :209-215.
3Yu J J, Lee K B, Mu C, et al. Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene[J]. Int J Oncol,2000,16(3):555-560.
4Park D J, Zhang W, Stoehlmacher, et al. ERCC1 gene polymor phism as a predictor for clinical outcome in advanced colorecta cancer patients treated with platinum based chemotherapy[J]. Clin Adv Hematol Oncol,2003,1 (3) : 162-166.
5Isla D, Sarries C, Rosell R, et al. Single nucleotide polymor-phisms and outcome in docetaxel-cisplatin treated advanced non- small-cell lung cancer[J]. Ann Oncol, 2004,15 (8) : 1194-1203.
6Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer[J]. Lung Canc er,2007,56(2) :281-288.
7Viguier J, Boige V, Miquel C, et al. ERCC1 codon 118 poly morphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer[J]. Clin Cancer Res, 2005,11 (17) : 6212-6217.
8Kang S, Ju W, Kim J W, et al. Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer[J]. Exp Mol Med, 2006,38(3) :320-324.
9Thornton K, Forstner M, Shen M R, et al. Purification, char acterization, and crystallization of the distal BRCT domain of the human XRCC1 DNA repair protein[J]. Protein Expr Purif, 1999, 16(2) : 236-242.
10Shen M R, Jones I M, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans[J]. Cancer Res, 1998, 58(4): 604-608.
